Respiratory depression in a neonate born to mother on maximum dose sertraline: a case report
- PMID: 33602307
- PMCID: PMC7893725
- DOI: 10.1186/s13256-020-02640-1
Respiratory depression in a neonate born to mother on maximum dose sertraline: a case report
Abstract
Background: Mood and anxiety disorders are common in women of childbearing age, especially during the peripartum period. As more women seek medical management for these conditions, there is an increasing need for studies to better examine the effects of exposure to selective serotonin reuptake inhibitors (SSRIs), and other antidepressants, on newborns at the time of delivery.
Case presentation: We report the case of a term Caucasian infant born to a 17-year-old white female taking 100 mg of sertraline daily for depression and anxiety who exhibited respiratory depression and hypoxia after an uncomplicated vaginal delivery. The neonate was treated with the use of continuous positive airway pressure (CPAP) and supplemental oxygen and subsequently the symptoms resolved without complication.
Conclusions: We present this case with the suspicion of poor neonatal adjustment syndrome as the possible cause of the respiratory depression and hypoxia in this newborn.
Keywords: Neonatal adjustment syndrome; Neonatal exposure; Perinatal; Sertraline.
Conflict of interest statement
All authors deny any competing interests in regards to this paper.
Similar articles
-
Transient neonatal jitteriness due to maternal use of sertraline (Zoloft).J Perinatol. 2004 Jun;24(6):392-4. doi: 10.1038/sj.jp.7211115. J Perinatol. 2004. PMID: 15167880
-
Serotonergic overstimulation in a preterm infant after sertraline intake via breastmilk.Breastfeed Med. 2013 Jun;8(3):327-9. doi: 10.1089/bfm.2012.0084. Epub 2012 Dec 18. Breastfeed Med. 2013. PMID: 23249132
-
Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.Pediatrics. 2003 Nov;112(5):e425. doi: 10.1542/peds.112.5.e425. Pediatrics. 2003. PMID: 14595087
-
An evidence-based review of the clinical use of sertraline in mood and anxiety disorders.Int Clin Psychopharmacol. 2009 Mar;24(2):43-60. doi: 10.1097/yic.0b013e3282f4b616. Int Clin Psychopharmacol. 2009. PMID: 21456103 Review.
-
[Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].Encephale. 2010 Jun;36 Suppl 2:D133-8. doi: 10.1016/j.encep.2009.06.005. Epub 2009 Sep 19. Encephale. 2010. PMID: 20513456 Review. French.
Cited by
-
Effect of Low and High Doses of Two Selective Serotonin Reuptake Inhibitors on Pregnancy Outcomes and Neonatal Mortality.Toxics. 2022 Jan 1;10(1):11. doi: 10.3390/toxics10010011. Toxics. 2022. PMID: 35051053 Free PMC article.
-
Current research in pathophysiology of opioid-induced respiratory depression, neonatal opioid withdrawal syndrome, and neonatal antidepressant exposure syndrome.Curr Res Toxicol. 2022 Jun 6;3:100078. doi: 10.1016/j.crtox.2022.100078. eCollection 2022. Curr Res Toxicol. 2022. PMID: 35734228 Free PMC article.
References
-
- Byrnes L. Perinatal mood and anxiety disorders. J Nurse Practitioners. 2018;14:507–513. doi: 10.1016/j.nurpra.2018.03.010. - DOI
-
- Committee on Obstetric Practice The American College of Obstetricians and Gynecologists Committee Opinion no 630. Screening for perinatal depression. Obstet Gynecol. 2015;125(5):1268–1271. - PubMed
-
- Yonkers KA, Wisner KL, Stewart DE, Oberlander TF, Dell DL, Stotland N, et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry. 2009;31(5):403–413. doi: 10.1016/j.genhosppsych.2009.04.003. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials